Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay

Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay

Objective: We assessed the clinical performance of novel Roche Elecsys SARS-CoV-2 Antigen fully automated electrochemiluminescence immunoassay (ECLIA). Design and methods: We tested 160 subjects, 110 (68.8%), with positive molecular test for SARS-CoV-2 infection in nasopharyngeal samples, with Alton...

Full description

Bibliographic Details
Main Authors: Gian Luca Salvagno, Laura Pighi, Simone De Nitto, Giuseppe Lippi
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Practical Laboratory Medicine
Subjects:
COVID-19
SARS-CoV-2
Laboratory medicine
Diagnosis
Immunoassay
Online Access:http://www.sciencedirect.com/science/article/pii/S235255172200004X

Internet

http://www.sciencedirect.com/science/article/pii/S235255172200004X

Similar Items